Related Experiment Video
Updated: Jun 19, 2026
08:31
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Joint hypermobility in patients with mitral valve prolapse
Simone Cavenaghi1, Lais Helena Carvalho Marino, Patrícia Pantaleão Oliveira
1Faculdade de Medicina de São José do Rio Preto, Rua Paraná 66, São José do Rio Preto, SP, Brazil. sicavenaghi@ig.com.br
Arquivos Brasileiros De Cardiologia
|October 24, 2009
Summary
Joint hypermobility is linked to mitral valve prolapse, a heart condition. Genetic changes affecting collagen are the likely cause of this association, highlighting a connection between connective tissues and cardiovascular health.
Area of Science:
- Cardiovascular Medicine
- Rheumatology
- Genetics
Background:
- Joint hypermobility is increasingly recognized for its association with various musculoskeletal disorders.
- Abnormalities in multiple organ systems, including the cardiovascular system, have been linked to hypermobility.
- Mitral valve prolapse (MVP) is one such cardiovascular abnormality noted in individuals with hypermobility.
Purpose of the Study:
- To investigate and review existing data on the association between joint hypermobility and mitral valve prolapse.
- To explore the underlying mechanisms potentially connecting these two conditions.
Main Methods:
- Literature review of studies investigating joint hypermobility and mitral valve prolapse.
- Analysis of data linking connective tissue abnormalities to cardiovascular manifestations.
Main Results:
- Evidence suggests a significant association between joint hypermobility and mitral valve prolapse.
- Genetic alterations affecting collagen composition appear to be a primary factor in this association.
Conclusions:
- Joint hypermobility and mitral valve prolapse share common etiological factors, particularly related to collagen.
- Further research into connective tissue disorders is warranted to understand and manage associated cardiovascular risks.
Related Concept Videos
01:27Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
01:19Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
01:20Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...